PMN ProMIS Neurosciences Inc.
Company Analysis
Latest News
🔴 ProMIS Neurosciences is trading 11% down today amid biotech-sector weakness
ProMIS Neurosciences is trading 10.89% lower at $8.51, with biotech-sector weakness a possible contributor. - No company-specific announcement explaining the...
🔴 ProMIS Neurosciences is trading 5.7% down amid biotech-sector pressure
ProMIS Neurosciences is trading 5.7% down at $9.01, with no company-specific announcement identified to explain the decline. - On October 13, 2026, XBI was...
🟢 ProMIS Neurosciences is trading 5% up with no clear catalyst identified
ProMIS Neurosciences is trading 5.44% higher at $9.74, with no clear company-specific catalyst identified. - No company-specific announcement dated October 9...
🔴 ProMIS Neurosciences is trading 5% down — no clear catalyst identified
ProMIS Neurosciences is trading 5.36% lower at $8.86, with no clear catalyst identified. - The decline is from the October 5 close of $9.37; no volume or...
🟢 ProMIS Neurosciences is trading 11% up today amid broader-market gains
ProMIS Neurosciences is trading 10.66% higher at $10.38, with the move consistent with broader market strength; no clear company-specific catalyst has been...
🟢 ProMIS Neurosciences is trading 6.8% up today as broader markets rise
ProMIS Neurosciences is trading at $10.02, up 6.77%, as broader market strength may be supporting the stock; no specific company catalyst for October 2 was...
🔴 ProMIS Neurosciences is trading 11.1% down; specific catalyst remains unclear
ProMIS Neurosciences is trading 11.1% down at $9.64, with no specific catalyst identified for the October 1, 2026 decline. - Its latest release, dated...
🔴 ProMIS Neurosciences is trading 6% down today with no confirmed company-specific catalyst
ProMIS Neurosciences is trading 5.62% down at $10.24, with no confirmed company-specific catalyst identified for October 1, 2026. - The company announced...
🟢 ProMIS Neurosciences is trading 11% up in pre-market with no confirmed catalyst
ProMIS Neurosciences is trading 10.6% higher at $12.00, versus its September 30 close of $10.85; no catalyst is confirmed for the pre-market move. - A sharp...
🟢 ProMIS Neurosciences is trading 5% up in pre-market — reason remains unclear
ProMIS Neurosciences is trading at $11.49, up 5.03% in pre-market; the reason for the gain remains unclear. - No confirmed company announcement explaining the...
🟢 ProMIS Neurosciences is trading 5.7% up in after-hours trading
ProMIS Neurosciences is trading 5.67% up in after-hours at $11.56; no confirmed late-breaking company announcement explaining the move was identified. - The...
🔴 ProMIS Neurosciences is trading 5% down
ProMIS Neurosciences is trading 5.19% lower at $10.69 on September 28, 2026, with no verified company-specific catalyst identified. - Broader markets were...
🔴 ProMIS Neurosciences is trading 10.66% down today amid macro-sensitive biotech selling
ProMIS Neurosciences is trading at $11.56 (-10.66%) as broad risk-off sentiment and biotech weakness weighed on shares. - No company-specific announcement was...
🔴 ProMIS Neurosciences is trading 6.49% down today as Treasury yields and crude oil rise
ProMIS Neurosciences is trading 6.49% down at $12.10, with the decline appearing primarily tied to broad risk-off trading as Treasury yields and crude oil...
🔴 ProMIS Neurosciences is trading 6.21% down today with no clear company-specific negative catalyst identified
ProMIS Neurosciences is trading 6.21% down now at $13.14, with no clear company-specific negative catalyst identified for September 21, 2026. - Its scheduled...
🟢 ProMIS Neurosciences is trading 5.76% up today as XBI rises 2.55%
ProMIS Neurosciences is trading 5.76% up at $14.14, with the move appearing mainly supported by biotechnology-sector strength; XBI is up 2.55% during regular...
🟢 ProMIS Neurosciences is trading 5% up today ahead of September 15, 2026 H.C. Wainwright presentation
ProMIS Neurosciences is trading at $13.93 (+5.05%) ahead of its scheduled September 15, 2026 H.C. Wainwright presentation at 10:30 a.m. ET. - The company is...
🟢 ProMIS Neurosciences is trading 17.91% up in pre-market after PMN310 safety findings
ProMIS Neurosciences is trading 17.91% up at $15.80 after management reiterated encouraging PMN310 safety and blinded biomarker findings during September 10...
🔴 ProMIS Neurosciences is trading 6.37% down today after 14.64% gain on September 9
ProMIS Neurosciences is trading 6.37% down at $13.45 amid a weaker market backdrop, with the Nasdaq Composite down 0.80% and the S&P 500 down 0.49%. - Shares...
ProMIS Reports Zero Brain-Swelling Cases in Alzheimer's Trial — But Can a $130M Biotech Ride Safety Data Alone to a Late-Stage Bet?
Shares surged 11.5% to $13.96 as ProMIS Neurosciences used a fireside chat at the Cantor Global Healthcare Conference to tout a clean safety record from its...